📢 Update: this account will no longer be active. Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/ We look forward to staying connected with you there!

Breaking Barriers: How Carthera’s SonoCloud Offers New Perspectives to Brain Cancer Patients 🧠 The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma. www.abta.org/mindmatters/...

🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma 🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8] 🇺🇸 #CNS2025 LA, 11-15 [Booth 588] 🇨🇿 #EANO2025 Prague, 16-19 [Booth 9] 💬 Drop by our booths or send us a DM to arrange a meeting

Finding a #braintumor clinical trial can be overwhelming. That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai

🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma 🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8] 🇺🇸 #CNS2025 LA, 11-15 [Booth 588] 🇨🇿 #EANO2025 Prague, 16-19 💬 Drop by our booths or send us a DM to arrange a meeting

GLIOBLASTOMA TRIAL UPDATE 📣 Sonobird is now active in Denmark! 🇩🇰 Two weeks ago, the team at University of Copenhagen included the first Danish patient. To learn more about the trial including active recruitment centres 👇 sonobird.eu #Glioblastoma #ClinicalTrial #NeuroOncology

🎙️ Our CSO Michael Canney was recently featured on the Med Tech Gurus podcast, where he dives into how our SonoCloud technology works and its potential to revolutionize glioblastoma care www.youtube.com/watch?v=3kUF... #NeuroOncology #ClinicalTrials #Glioblastoma #MedTech

Summer Review: Transforming Glioblastoma Treatment 🧠 🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma Interviews & Podcast access 👉 linktr.ee/carthera

📣 Our CSO Michael Canney discussed our innovative approach to treating recurrent #glioblastoma on the Brain Wellness podcast. He explains how we use therapeutic ultrasound to enhance chemotherapy delivery to the brain. www.youtube.com/watch?v=KcUu... #MedTech #BrainCancer #ClinicalTrials

📣 Our CSO, Michael Canney talks all things Sonobird on the Bindwaves podcast. Learn about SonoCloud-9, our ultrasound implant that disrupts the blood-brain barrier to enhance the delivery of therapeutic drugs. www.youtube.com/watch?v=B2_D... #Glioblastoma #BrainCancer #Oncology #ClinicalTrials

This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients Learn more about the trial and clinical sites in Italy👇 sonobird.eu #clinicaltrials #medtech

📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹 Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial. Watch the interview👇 bit.ly/4msq3gX

A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes. Learn more👇 www.insideprecisionmedicine.com/topics/oncol... #BrainTumor #Oncology

🧠 Purdue University Researchers Develop a Novel Human Brain Model to Study Alzheimer’s Disease vet.purdue.edu/news/purdue-... #Alzheimers

🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments. Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system. Read Lynn's story - a patient in our Sonobird trial👇 www.med.unc.edu/neurosurgery...

🔊 New podcast! Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain. Listen here: www.youtube.com/watch?v=lvRU... #Glioblastoma #Oncology #ClinicalTrial

Exciting news! Our SonoCloud is among the first devices to receive a positive opinion from the EMA expert panel for Orphan Medical Device status, targeting recurrent glioblastoma. A big step toward CE marking! ala.associates/regulatory/c... #Glioblastoma #Oncology #MedTech #NeuroOncology

Our CSO was recently featured on The Childhood Cancer Perspective Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq... #BrainCancerResearch #Glioblastoma #MedicalBreakthroughs

Our CSO was recently featured on the PsyDactic podcast! 📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera? Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis... #Ultrasound #Research #Podcast

Le Pr. Olivier Chinot de @aphm-chu-marseille.bsky.social était ce matin sur @bfmmarseille.bsky.social 📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re... #glioblastome #Santé #RechercheMédicale

Our CSO will be onsite to present a poster about the Sonobird trial for rGBM during the International Society for Therapeutic Ultrasound event in Banff, Alberta, Canada from 21-24 June, 2025! Find out more about the event and how you can register here👇 istu.org #ISTU2025 #focusedultrasound

🎧 LISTEN IN: Sound waves meet brain science. In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases. Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu podcasts.apple.com/us/podcast/e...

How do we overcome the blood-brain barrier ? 🧠 Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle. In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption. www.cureus.com/articles/353...

It's #ClinicalTrialsDay! Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.

Don't miss this article from NewYork-Presbyterian and @columbiacancer.bsky.social spotlighting our SONOBIRD trial Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation www.nyp.org/advances/art... #Glioblastoma #BrainTumor #ClinicalTrials

This weekend, our Chief Scientific Officer spoke with @foxnews.com.web.brid.gy to break down what people should know about glioblastoma following Michael Bolton's diagnosis, and how Carthera is advancing progress toward new breakthroughs in treatment delivery. Full article: bit.ly/42ZTdM9

Our innovative SonoCloud technology has been used to treat the first glioblastoma patient in Florida! A huge thank you to @moffittnews.bsky.social for their dedication and expertise in making this possible. Want to learn more ? www.moffitt.org/endeavor/arc... #Glioblastoma #ClinicalTrials

📢 Tomorrow our team will be at the American Association of Neurological Surgeons' Annual Meeting! Visit us at Booth 1352 to learn about Sonobird, our pivotal trial in recurrent #glioblastoma🧠 annualmeeting.aans.org #AANS2025 #glioblastoma #neurosurgery

📣 CLINICAL TRIAL MILESTONE We are thrilled to share that we have recruited 100 patients to our SONOBIRD pivotal trial across the EU and US in the world's largest ever trial performed on glioblastoma patients using ultrasound-based blood-brain barrier opening 🧠 ala.associates/clinical/car...

🥼University of Minnesota researchers are developing a cell therapy that would combat Alzheimer’s disease using strategies used in blood cancer treatment 👉https://bit.ly/42IJb2a #Alzheimers #Neurology #CellTherapy

📢 In 2 weeks our clinical team will be in Boston for the American Association of Neurological Surgeons' Annual Meeting! Drop by Booth 1352 to learn insights into Sonobird, our pivotal trial in recurrent glioblastoma 🧠 Event details👇 annualmeeting.aans.org #AANS2025 #glioblastoma #neurosurgery

📺 Learn how our SonoCloud system works to disrupt the blood-brain barrier to enhance the delivery of therapeutic agents to brain tissues 🧠 www.youtube.com/watch?v=HhcO... #SonoCloud #BBB #neurology #medtech #therapeuticultrasound

The Oxford Drug Discovery Institute is using artificial intelligence and ‘knowledge graphs’ to sift through vast amounts of biomedical data, potentially leading to faster treatments - @wsj.com www.wsj.com/articles/ai-... #Alzheimers #AI #Neurology

📢 Next month our clinical team will be in Boston for the American Association of Neurological Surgeons' Annual Meeting! Come at Booth 1352 to learn insights into Sonobird, our pivotal trial in recurrent glioblastoma🧠 Event details👇 annualmeeting.aans.org #AANS2025 #glioblastoma #neurosurgery

@cambridgeuni.bsky.social PhD student Sarah Nicholls talks about her research on the protein tau and the role it might play in #Alzheimers Disease www.gatescambridge.org/about/news/e... #tau #neurology #neurodegenerative

🥼 Researchers at UT Southwestern have found that transcranial direct current stimulation temporarily improved some patients’ cognitive skills in a preliminary trial www.utsouthwestern.edu/newsroom/art... #Alzheimers #Neurostimulation #Neurology

🗞️ Accelerating the search for new #glioblastoma treatments Interesting read on @cancerresearchuk.org by @oh-henry.bsky.social news.cancerresearchuk.org/2025/03/04/a...

Want to learn more about our Sonobird trial? Watch this webinar with Principal Investigator, Dr Adam Sonabend where he talks about how our SonoCloud device is being used to treat #glioblastoma👇 🔗 www.youtube.com/watch?v=P66x... #oncology #medtech

🧠 Researchers have uncovered how microbubbles open the blood-brain barrier Read the full article👇 www.technologynetworks.com/tn/news/how-... #BBB #DrugDelivery

📣GLIOBLASTOMA TRIAL ALERT! Our SONOBIRD trial is now open in the US & Europe! Today’s spotlight: Dallas🇺🇸 Dr Toral Patel and her team will be supporting patients at University of Texas Southwestern Medical Center🏥 Trial details👇 sonobird.eu #glioblastoma #oncology #clinicaltrial #medtech

🗞️According to an article published in @nature.com repurposed drugs provide a rich source of potential therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders (NDD) Read the full article👇 www.nature.com/articles/s41... #Alzheimers #Neurodegenerative #Neurology

@neurosurgerynm.bsky.social investigators have discovered unique genetic and structural changes in endothelial cells in the brain after disrupting the blood-brain barrier in patients with recurrent #glioblastoma news.feinberg.northwestern.edu/2025/02/24/b... #Neurology #BBB

Want to know more about our Sonobird trial? Check out this Q&A with our CCO Carole Desseaux, CSO Michael Canney, and PI Adam Sonabend on therapeutic ultrasound for recurrent #glioblastoma 👉 www.fusfoundation.org/posts/therap...

📑 Our CSO Michael Canney worked with the @fusfoundation.bsky.social to produce a meeting report for EANO 2024 (@eanoassociation.bsky.social) During the event, we hosted a meeting for investigators involved in our SONOBIRD trial🥼 Read the full report👇 www.fusfoundation.org/posts/meetin...

📣GLIOBLASTOMA TRIAL ALERT! Our SONOBIRD trial is now open in the US & Europe! Today’s spotlight: Liége🇧🇪 Pr. Pierre Frères and his team will be supporting patients at CHU de Liège🏥 Trial details👇 sonobird.eu #glioblastoma #oncology #clinicaltrial #medtech

📑 Our CSO Michael Canney worked with the @fusfoundation.bsky.social to produce a meeting report for EANO 2024 (@eanoassociation.bsky.social) During the event, we hosted a meeting for investigators involved in our SONOBIRD trial🥼 Read the full report👇 www.fusfoundation.org/posts/meetin...

📣GLIOBLASTOMA TRIAL ALERT! Our SONOBIRD trial is now open in the US & Europe! Today’s spotlight: Denver🇺🇸 Dr Kevin Lillehei and his team will be supporting patients at University of Colorado Cancer Center🏥 Trial details👇 sonobird.eu #glioblastoma #oncology #clinicaltrial #medtech

🗞️ New research sheds light on brain inflammation in Alzheimer's www.news-medical.net/news/2025021... #Alzheimers #Research #Inflammation

📣GLIOBLASTOMA TRIAL ALERT Our SONOBIRD trial is now open in the US & Europe. Today’s spotlight: Baltimore🇺🇸 Dr. Chetan Bettegowda and his team will be supporting patients at Johns Hopkins University🏥 Trial details👇 sonobird.eu #glioblastoma #oncology #clinicaltrial #medtech

🗞️ Novel method for generating antibodies could revolutionize Alzheimer's and Parkinson's research www.news-medical.net/news/2025021... #Parkinsons #Alzheimers #research #antibodies